n,n-dimethylarginine has been researched along with isoxazoles in 3 studies
Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (isoxazoles) | Trials (isoxazoles) | Recent Studies (post-2010) (isoxazoles) |
---|---|---|---|---|---|
2,216 | 228 | 1,221 | 8,633 | 900 | 3,337 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chouinard, M; Cox, AL; Ficorilli, J; Gao, H; Hu, T; Li, S; Marcelo, M; Michael, LF; Michael, MD; Ryan, TP; Sipes, P | 1 |
Gao, X; Kuruba, R; Li, J; Li, S; Liu, Y; Pitt, B; Poloyac, S; Wilson, A; Xie, W | 1 |
Brzozowski, T; Jasnos, K; Krzysiek-Maczka, G; Kwiecien, S; Magierowski, M; Ptak-Belowska, A; Sliwowski, Z; Surmiak, M | 1 |
3 other study(ies) available for n,n-dimethylarginine and isoxazoles
Article | Year |
---|---|
Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation.
Topics: Amidohydrolases; Animals; Arginine; Cell Line; DNA-Binding Proteins; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Humans; Isoxazoles; Liver; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2006 |
Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine.
Topics: Amidohydrolases; Animals; Arginine; Cationic Amino Acid Transporter 1; Cell Line; Cells, Cultured; Haplorhini; Humans; Isoxazoles; Kidney; Liver; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase; Receptors, Cytoplasmic and Nuclear | 2009 |
Exogenous asymmetric dimethylarginine (ADMA) in pathogenesis of ischemia-reperfusion-induced gastric lesions: interaction with protective nitric oxide (NO) and calcitonin gene-related peptide (CGRP).
Topics: Animals; Arginine; Blood Flow Velocity; Calcitonin Gene-Related Peptide; Capsaicin; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Gastric Mucosa; Interleukin-10; Isoxazoles; Male; Malondialdehyde; Nitric Oxide; Rats, Wistar; Reperfusion Injury; Stomach Diseases; Tumor Necrosis Factor-alpha | 2014 |